Erectile Dysfunction Drugs Market By Drug-
Erectile Dysfunction Drugs Market By Mode of Administration-
Erectile Dysfunction Drugs Market By Distribution Channel-
Erectile Dysfunction Drugs Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Erectile Dysfunction Drugs Market Snapshot
Chapter 4. Global Erectile Dysfunction Drugs Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Drug Estimates & Trend Analysis
5.1. by Drug & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Drug:
5.2.1. Avanafil (Stendra)
5.2.2. Muse Suppository (Alprostadil)
5.2.3. Sildenafil (Viagra)
5.2.4. Tadalafil (Cialis)
5.2.5. Vardenafil (Levitra, Staxyn)
Chapter 6. Market Segmentation 2: by Mode of Administration Estimates & Trend Analysis
6.1. by Mode of Administration & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Mode of Administration:
6.2.1. Injections
6.2.2. Oral
6.2.3. Topical
Chapter 7. Market Segmentation 3: by Distribution Channel Estimates & Trend Analysis
7.1. by Distribution Channel & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Distribution Channel:
7.2.1. Hospital Pharmacies
7.2.2. Online Pharmacies
7.2.3. Retail Pharmacies
Chapter 8. Erectile Dysfunction Drugs Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Erectile Dysfunction Drugs Market Revenue (US$ Million) Estimates and Forecasts by Drug, 2019-2031
8.1.2. North America Erectile Dysfunction Drugs Market Revenue (US$ Million) Estimates and Forecasts by Mode of Administration, 2019-2031
8.1.3. North America Erectile Dysfunction Drugs Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
8.1.4. North America Erectile Dysfunction Drugs Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Erectile Dysfunction Drugs Market Revenue (US$ Million) Estimates and Forecasts by Drug, 2019-2031
8.2.2. Europe Erectile Dysfunction Drugs Market Revenue (US$ Million) Estimates and Forecasts by Mode of Administration, 2019-2031
8.2.3. Europe Erectile Dysfunction Drugs Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
8.2.4. Europe Erectile Dysfunction Drugs Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Erectile Dysfunction Drugs Market Revenue (US$ Million) Estimates and Forecasts by Drug, 2019-2031
8.3.2. Asia Pacific Erectile Dysfunction Drugs Market Revenue (US$ Million) Estimates and Forecasts by Mode of Administration, 2019-2031
8.3.3. Asia-Pacific Erectile Dysfunction Drugs Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
8.3.4. Asia Pacific Erectile Dysfunction Drugs Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Erectile Dysfunction Drugs Market Revenue (US$ Million) Estimates and Forecasts by Drug, 2019-2031
8.4.2. Latin America Erectile Dysfunction Drugs Market Revenue (US$ Million) Estimates and Forecasts by Mode of Administration, 2019-2031
8.4.3. Latin America Erectile Dysfunction Drugs Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
8.4.4. Latin America Erectile Dysfunction Drugs Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Erectile Dysfunction Drugs Market Revenue (US$ Million) Estimates and Forecasts by Drug, 2019-2031
8.5.2. Middle East & Africa Erectile Dysfunction Drugs Market Revenue (US$ Million) Estimates and Forecasts by Mode of Administration, 2019-2031
8.5.3. Middle East & Africa Erectile Dysfunction Drugs Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2019-2031
8.5.4. Middle East & Africa Erectile Dysfunction Drugs Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Adamed Sp. z o.o.
9.2.2. Bayer AG
9.2.3. Cipla Limited
9.2.4. Dr. Reddys Laboratories Ltd.
9.2.5. Eli Lilly and Company
9.2.6. Endo International PLC
9.2.7. Futura Medical PLC
9.2.8. GlaxoSmithKline PLC
9.2.9. Johnson & Johnson Services Inc.
9.2.10. Novartis International AG
9.2.11. Pfizer Inc.
9.2.12. S.K. Chemicals Co. Ltd.
9.2.13. Sanofi S.A.
9.2.14. Sun Pharmaceutical Industries Ltd.
9.2.15. Teva Pharmaceutical Industries Ltd.
9.2.16. Vivus, Inc.
9.2.17. Other Prominent Players
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.